192 related articles for article (PubMed ID: 17289879)
1. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
[TBL] [Abstract][Full Text] [Related]
2. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
[TBL] [Abstract][Full Text] [Related]
3. Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway.
Lee YL; Chan YL; Chow WN; Ng EH; Lee KF; Yeung WS; Ho PC
Fertil Steril; 2009 May; 91(5 Suppl):2163-71. PubMed ID: 18571163
[TBL] [Abstract][Full Text] [Related]
4. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.
Pasquali D; Rossi V; Staibano S; De Rosa G; Chieffi P; Prezioso D; Mirone V; Mascolo M; Tramontano D; Bellastella A; Sinisi AA
Endocrinology; 2006 Sep; 147(9):4245-51. PubMed ID: 16763065
[TBL] [Abstract][Full Text] [Related]
5. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors.
Masuda Y; Takatsu Y; Terao Y; Kumano S; Ishibashi Y; Suenaga M; Abe M; Fukusumi S; Watanabe T; Shintani Y; Yamada T; Hinuma S; Inatomi N; Ohtaki T; Onda H; Fujino M
Biochem Biophys Res Commun; 2002 Apr; 293(1):396-402. PubMed ID: 12054613
[TBL] [Abstract][Full Text] [Related]
6. Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.
Tabata S; Goi T; Nakazawa T; Kimura Y; Katayama K; Yamaguchi A
Oncol Rep; 2013 Feb; 29(2):459-63. PubMed ID: 23135359
[TBL] [Abstract][Full Text] [Related]
7. Prokineticin-signaling pathway.
Ngan ES; Tam PK
Int J Biochem Cell Biol; 2008; 40(9):1679-84. PubMed ID: 18440852
[TBL] [Abstract][Full Text] [Related]
8. Endocrine glands-derived vascular endothelial growth factor protects pancreatic cancer cells from apoptosis via upregulation of the myeloid cell leukemia-1 protein.
Ren LN; Li QF; Xiao FJ; Yan J; Yang YF; Wang LS; Guo XZ; Wang H
Biochem Biophys Res Commun; 2009 Aug; 386(1):35-9. PubMed ID: 19523441
[TBL] [Abstract][Full Text] [Related]
9. Prokineticin-1 (Prok-1) works coordinately with glial cell line-derived neurotrophic factor (GDNF) to mediate proliferation and differentiation of enteric neural crest cells.
Ngan ES; Shum CK; Poon HC; Sham MH; Garcia-Barcelo MM; Lui VC; Tam PK
Biochim Biophys Acta; 2008 Mar; 1783(3):467-78. PubMed ID: 18006159
[TBL] [Abstract][Full Text] [Related]
10. Unique expression and regulatory mechanisms of EG-VEGF/prokineticin-1 and its receptors in the corpus luteum.
Kisliouk T; Podlovni H; Meidan R
Ann Anat; 2005 Nov; 187(5-6):529-37. PubMed ID: 16320832
[TBL] [Abstract][Full Text] [Related]
11. Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells.
Kisliouk T; Levy N; Hurwitz A; Meidan R
J Clin Endocrinol Metab; 2003 Aug; 88(8):3700-7. PubMed ID: 12915658
[TBL] [Abstract][Full Text] [Related]
12. Prokineticin-1 modulates proliferation and differentiation of enteric neural crest cells.
Ngan ES; Lee KY; Sit FY; Poon HC; Chan JK; Sham MH; Lui VC; Tam PK
Biochim Biophys Acta; 2007 Apr; 1773(4):536-45. PubMed ID: 17324478
[TBL] [Abstract][Full Text] [Related]
13. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
Li Q; Xu B; Fu L; Hao XS
J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981
[TBL] [Abstract][Full Text] [Related]
14. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) expression in colorectal cancer.
Nagano H; Goi T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
J Surg Oncol; 2007 Dec; 96(7):605-10. PubMed ID: 17786959
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells.
Keramidas M; Faudot C; Cibiel A; Feige JJ; Thomas M
J Endocrinol; 2008 Mar; 196(3):473-82. PubMed ID: 18310443
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
17. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.
Oberthuer A; Hero B; Spitz R; Berthold F; Fischer M
Clin Cancer Res; 2004 Jul; 10(13):4307-13. PubMed ID: 15240516
[TBL] [Abstract][Full Text] [Related]
18. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.
Hoffmann P; Feige JJ; Alfaidy N
Placenta; 2007 Oct; 28(10):1049-58. PubMed ID: 17531315
[TBL] [Abstract][Full Text] [Related]
19. Endocrine gland-derived vascular endothelial growth factor in rat pancreas: genetic expression and testosterone regulation.
Morales A; Morimoto S; Díaz L; Robles G; Díaz-Sánchez V
J Endocrinol; 2008 May; 197(2):309-14. PubMed ID: 18434360
[TBL] [Abstract][Full Text] [Related]
20. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.
Tanaka N; Fukuzawa M
Int J Oncol; 2008 Oct; 33(4):815-21. PubMed ID: 18813796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
